|
|
|
Insider
Information: |
Luo Mary Z. |
Relationship: |
COO,Chief Scientist & ... |
City: |
Rancho Cucamonga |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
2,433,554 |
|
Indirect Shares
|
8,057,435 |
|
|
Direct
Value |
$101,333,189 |
|
|
Indirect Value
|
$335,511,593 |
|
|
Total
Shares |
10,490,989 |
|
|
Total
Value |
$436,844,782 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Amphastar Pharmaceuticals, Inc. |
AMPH |
COO,Chief Scientist & ... |
2024-03-17 |
2,433,554 |
2024-03-17 |
8,057,435 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
170 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
|
2018-05-15 |
4 |
B |
$16.08 |
$401,970 |
D/D |
25,000 |
2,065,619 |
3.23 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
|
2021-03-16 |
4 |
D |
$18.44 |
$465,444 |
D/D |
(25,241) |
2,193,659 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
CEO & Chief Scientific Officer |
|
2022-03-16 |
4 |
D |
$34.22 |
$863,747 |
D/D |
(25,241) |
2,357,782 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
|
2023-03-16 |
4 |
D |
$37.60 |
$949,062 |
D/D |
(25,241) |
2,094,486 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2015-06-09 |
4 |
AS |
$16.24 |
$417,255 |
D/D |
(25,700) |
922,137 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2015-06-09 |
4 |
AS |
$16.12 |
$415,971 |
I/I |
(25,800) |
673,524 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2016-03-27 |
4 |
D |
$11.96 |
$309,238 |
D/D |
(25,856) |
1,088,335 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
|
2020-03-16 |
4 |
D |
$13.03 |
$337,125 |
D/D |
(25,873) |
2,094,264 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO & Chief Scientist |
|
2015-12-09 |
4 |
AS |
$14.29 |
$376,133 |
I/I |
(26,319) |
7,498,575 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2015-06-08 |
4 |
AS |
$16.61 |
$448,910 |
D/D |
(27,020) |
919,513 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2015-06-08 |
4 |
AS |
$16.61 |
$450,096 |
I/I |
(27,100) |
670,891 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2024-03-04 |
4 |
A |
$0.00 |
$0 |
I/I |
27,110 |
1,131,526 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
|
2020-03-15 |
4 |
D |
$14.19 |
$385,670 |
D/D |
(27,179) |
2,120,137 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO Chief Scientist & Chairman |
|
2019-03-16 |
4 |
D |
$20.23 |
$555,839 |
D/D |
(27,476) |
2,179,690 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist Chairman |
|
2017-03-27 |
4 |
D |
$14.27 |
$392,140 |
D/D |
(27,480) |
1,172,502 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, COB |
|
2021-03-15 |
4 |
D |
$19.15 |
$537,885 |
D/D |
(28,088) |
2,218,900 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2015-06-09 |
4 |
OE |
$12.97 |
$367,362 |
D/D |
28,324 |
947,837 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2015-06-09 |
4 |
OE |
$12.97 |
$368,776 |
I/I |
28,433 |
699,324 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO & Chief Scientist |
|
2015-12-04 |
4 |
AS |
$14.95 |
$429,302 |
I/I |
(28,712) |
7,564,299 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
|
2018-12-13 |
4 |
S |
$20.99 |
$623,166 |
I/I |
(29,689) |
7,327,679 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2015-06-08 |
4 |
OE |
$12.97 |
$389,956 |
D/D |
30,066 |
946,533 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2015-06-08 |
4 |
OE |
$12.97 |
$391,071 |
I/I |
30,152 |
697,991 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2018-03-17 |
4 |
D |
$19.91 |
$606,996 |
D/D |
(30,487) |
2,061,347 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO Chief Scientist & Chairman |
|
2019-03-17 |
4 |
D |
$20.23 |
$654,926 |
D/D |
(32,374) |
2,147,316 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
CEO & Chief Scientific Officer |
|
2022-03-15 |
4 |
A |
$0.00 |
$0 |
I/I |
32,412 |
1,520,783 |
0 |
- |
|
170 Records found
|
|
Page 4 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|